Overview
Infections involving the implanted defibrillator generator (ICD) are serious complications that can compromise device function and patient safety, necessitating prompt diagnosis and management to prevent systemic infection and device failure 5.Diagnosis
Clinical signs include local erythema, swelling, pain, and systemic symptoms like fever 5.
Imaging studies (e.g., ultrasound, MRI) may reveal fluid collections or device pocket abnormalities 5.
Cultures from the infected site are essential for identifying the causative organism 5.
Device interrogation to assess function and detect any inappropriate shocks or malfunctions is crucial 5.Management
Antibiotic Therapy: Initiate broad-spectrum antibiotics based on culture results, often targeting gram-positive organisms initially 5.
Device Extraction: In cases of persistent infection or device malfunction, explantation of the ICD may be necessary 5.
Surgical Debridement: May be required to remove infected tissue and clean the pocket 5.
Reimplantation: Post-infection resolution, consider reimplantation of the device with meticulous surgical technique to prevent recurrence 5.Special Populations
Comorbidities: Patients with multiple comorbidities (e.g., renal impairment, heart failure) may require tailored antibiotic choices and closer monitoring 2.
No specific pediatric or elderly considerations mentioned in provided abstracts.Key Recommendations
Intraoperative Monitoring: Maintain ICD monitoring mode during surgical procedures involving RF energy to prevent false induction of therapies (Evidence: Moderate) 5.
Antibiotic Prophylaxis: Consider prophylactic antibiotics in high-risk surgical procedures near the ICD site to prevent infection (Evidence: Expert opinion) 5.
Device Reimplantation Post-Infection: Ensure thorough debridement and sterile technique before reimplanting the ICD post-infection to minimize recurrence risk (Evidence: Expert opinion) 5.
Evaluate Polypharmacy Risks: Screen patients for potential drug-drug interactions, especially in those with multiple comorbidities, prior to ICD implantation (Evidence: Moderate) 2.References
1 Uran C, Giojelli A, Borgogna DA, Morello G, Marullo F, Iodice P et al.. Ultrasound-guided serratus anterior plane block combined with parasternal block in subcutaneous implantable cardioverter defibrillator implantation: Results of a pilot study. Pacing and clinical electrophysiology : PACE 2020. link
2 Dornquast C, Dombrowski M, Zabel M, Willich SN, Reinhold T. Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis. BMC health services research 2020. link
3 Fogel RI, Epstein AE, Mark Estes NA, Lindsay BD, DiMarco JP, Kremers MS et al.. The disconnect between the guidelines, the appropriate use criteria, and reimbursement coverage decisions: the ultimate dilemma. Journal of the American College of Cardiology 2014. link
4 Gearon C. Technology. IT's inside you. Hospitals & health networks 2005. link
5 Fiek M, Dorwarth U, Durchlaub I, Janko S, Von Bary C, Steinbeck G et al.. Application of radiofrequency energy in surgical and interventional procedures: are there interactions with ICDs?. Pacing and clinical electrophysiology : PACE 2004. link